Stock Events

Stock Events

Lineage Cell Therapeutics (LCTX.TA) Q3 2025 Earnings

12AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-44.43

-32

-19.56

-7.12

Details

Expected EPS

-9.114727266

Actual EPS

-44.43374

Surprise EPS

-35.32

Surprise Percent

+387.49%

Description

Lineage Cell Therapeutics (LCTX.TA) has reported earnings of -44.43374 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.